EU MDR & IVDR Simplification: What the 2025 Proposal Means for MedTech

This episode unpacks the European Commission's significant proposal of December 16, 2025, aimed at the targeted simplification of the MDR and IVDR. We explore the potential impacts on documentation, digitalization through EUDAMED, and what these changes could mean for manufacturers, especially SMEs, as they navigate the complex European regulatory landscape. Key Questions: - What specific changes are included in the EU Commission's "targeted simplification" proposal? - How could the proposed MDR/IVDR updates affect documentation and compliance costs? - What role will digitalization and the mandatory use of EUDAMED play in the future? - Are Small and Medium-sized Enterprises (SMEs) specifically addressed in this proposal? - What is the legislative timeline, and when might these changes take effect? - Should manufacturers alter their current regulatory strategy based on this news? - How will the proposal impact market access and device availability in the EU? Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI and data tools to streamline global market access. We develop efficient pathways for regulatory approval, using AI to compile and submit technical documents, and act as your local representative in over 30 markets. Whether you're a startup or a multinational enterprise, our technology-driven approach ensures you can navigate complex environments and bring innovations to market faster. Visit us at https://pureglobal.com/, contact [email protected], or explore our FREE AI tools and database at https://pureglobal.ai.